| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Parry Agro Industries Limited |
|
Particulars |
31/03/2025 |
31/03/2024 |
|
Non-Current Assets |
|
|
|
Property, Plant and Equipment |
4,567.91 |
4,432.64 |
|
Right of use assets |
160.36 |
183.07 |
|
Capital work-in-progress |
429.99 |
675.30 |
|
Investments |
559.29 |
307.48 |
|
Other financial assets |
247.48 |
226.33 |
|
Deferred Tax Assets (Net) |
22.84 |
74.93 |
|
Other non-current assets |
14.13 |
32.94 |
|
Current Assets |
|
|
|
Inventories |
3,272.81 |
3,089.58 |
|
Biological Assets other than Bearer Plants |
64.86 |
55.61 |
|
Investments |
1,021.04 |
1,094.06 |
|
Trade receivables |
651.75 |
560.96 |
|
Cash and cash equivalents |
216.21 |
221.16 |
|
Bank Balances other than above |
160.35 |
138.46 |
|
Other financial assets |
49.91 |
45.93 |
|
Other Current assets |
254.72 |
249.70 |
|
Total Assets |
11,693.65 |
11,388.15 |
|
Equity |
|
|
|
Equity Share capital |
375.68 |
375.68 |
|
Other equity |
6,478.77 |
6,238.80 |
|
Non-current Liabilities |
|
|
|
Lease liabilities |
174.34 |
168.28 |
|
Provisions |
451.61 |
412.91 |
|
Current Liabilities |
|
|
|
Lease liabilities |
21.61 |
44.14 |
|
Trade Payables: |
|
|
|
Total outstanding dues to Micro
Enterprises and Small |
31.16 |
32.34 |
|
Total outstanding dues of creditors other
than Micro Enterprises and Small Enterprises |
377.10 |
525.74 |
|
Other financial liabilities |
2,383.20 |
2,116.44 |
|
Other current liabilities |
222.03 |
195.27 |
|
Provisions |
971.38 |
1,202.75 |
|
Current Tax Liabilities (Net) |
206.77 |
75.80 |
|
Total Equity and Liabilities |
11,693.65 |
11,388.15 |
|
Particulars |
31/03/2025 |
31/03/2024 |
|
Revenue from operations |
24,635.62 |
23,338.67 |
|
Other Income |
213.82 |
628.14 |
|
Total Income |
24,849.44 |
23,966.81 |
|
Expenses |
|
|
|
Cost of Material Consumed |
5,088.40 |
5,104.03 |
|
Purchase of Tea |
1,956.48 |
1,352.46 |
|
Changes in Inventories of Finished Goods
and Stock-in-trade |
-261.29 |
-318.39 |
|
Loss / (Gain) on transformation of
Biological Assets |
-9.25 |
-12.99 |
|
Employee benefits expense |
11,257.49 |
11,270.22 |
|
Finance Costs |
20.47 |
22.04 |
|
Depreciation and amortization expense |
477.58 |
491.05 |
|
Other expenses |
6,504.79 |
6,919.15 |
|
Total Expenses |
25,034.67 |
24,827.57 |
|
Share of Profit from Associate |
254.70 |
145.28 |
|
Profit / (Loss) from operations
before Exceptional items and tax |
|
|
|
Tax Expense - Current |
67.21 |
- |
|
Tax Expense - Deferred |
19.52 |
52.31 |
|
Profit/(Loss) for the period |
-17.26 |
-767.79 |
|
Other Comprehensive Income |
|
|
|
Remeasurement of the defined benefit plans |
292.69 |
60.02 |
|
Fair value loss on investments in equity
instruments designated as at FVTOCI |
- |
-387.80 |
|
Taxes relating to items above |
-32.57 |
32.10 |
|
Share of Other comprehensive income of
associate |
-2.89 |
-1.40 |
|
Total Comprehensive Income / (Loss)
for the year |
239.97 |
-1,064.87 |
|
Earnings per share |
|
|
|
Basic |
-0.46 |
-20.44 |
|
Diluted |
-0.46 |
-20.44 |
|
Particulars |
31/03/2025 |
31/03/2024 |
|
Cash flow from operating activities |
|
|
|
Net Profit/(Loss) before tax |
69.47 |
-715.48 |
|
Adjustments: |
|
|
|
Share of Profit from Associate |
-254.70 |
-145.28 |
|
Depreciation and Amortisation expense |
477.58 |
491.05 |
|
Finance Costs |
20.47 |
22.04 |
|
Interest Income |
-19.37 |
-54.17 |
|
Provision for Contingency |
23.36 |
20.81 |
|
Provision for doubtful debts |
3.66 |
- |
|
Profit on sale of current investments |
-24.28 |
-14.86 |
|
Fair Value changes in current investments |
-20.83 |
-31.45 |
|
Provision for expenses no longer required
written back |
-34.69 |
-433.25 |
|
Provision towards other items |
11.35 |
- |
|
Loss on Sale of Property, Plant and
Equipment |
2.42 |
4.57 |
|
Unrealised exchange variation (Net) |
7.96 |
-4.98 |
|
Operating
profit before working capital changes |
262.40 |
-861.00 |
|
Movements
in working capital: |
|
|
|
Increase /(decrease) in trade receivables |
-98.75 |
-3.15 |
|
Increase /(decrease) in Other Financial Assets |
-27.37 |
78.49 |
|
Decrease/ (Increase) in Inventories |
-202.80 |
-296.25 |
|
Decrease/ (Increase) in Other Assets |
46.11 |
24.72 |
|
(Increase) /decrease in Trade Creditors |
-149.82 |
118.86 |
|
Increase /(decrease) in Other Financial
Liabilities |
266.78 |
58.30 |
|
Increase/ (Decrease) in Other Liabilities |
142.82 |
206.55 |
|
Cash
used in operations |
239.37 |
-685.49 |
|
Income Taxes Paid |
- |
-12.00 |
|
Net Cash flow from operating
activities |
239.37 |
-685.49 |
|
Cash Flow From Investing Activities |
|
|
|
Capital Expenditure (net of subsidy received) |
-333.57 |
-105.79 |
|
Proceeds from sale of Property, Plant and
Equipment |
20.83 |
20.84 |
|
Purchase of Investments |
-563.32 |
-995.49 |
|
Sale of Investments |
681.45 |
1,598.12 |
|
Interest Received |
21.19 |
36.60 |
|
Bank Balances not considered as cash and
cash equivalents |
-21.90 |
261.68 |
|
Net Cash flow from / (used in)
Investing activities |
-195.32 |
815.96 |
|
Cash flow from Financing Activities |
|
|
|
Interest paid |
-20.23 |
-21.56 |
|
Repayment of Lease Liabilities |
-28.77 |
-27.12 |
|
Net Cash flow from / (used in)
Financing activities |
-49.00 |
-48.68 |
|
Net increase/(decrease) in cash and
cash equivalents |
-4.95 |
81.80 |
|
Cash and cash equivalents at the beginning
of the year |
221.16 |
139.36 |
|
Cash and cash equivalents at the end
of the year |
216.21 |
221.16 |
